Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy, Pharmacogenomics, Future Medicine

Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy, Pharmacogenomics, Future Medicine

Summary

Pharmacogenomics

February 2013, Vol. 14, No. 3, Pages 315-324 , DOI 10.2217/pgs.12.213

(doi:10.2217/pgs.12.213)

Review

Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy

Liming Weng​‌¹, Li Zhang​‌², Yan Peng​‌³ & R Stephanie Huang​‌^*1

* Author for correspondence

In the past decade, advances in pharmacogenetics and pharmacogenomics (PGx) have gradually unveiled the genetic basis of interindividual differences in drug responses. A large portion of these advances have been made in the field of anticancer therapy. Currently, the US FDA has updated the package inserts of approximately 30 anticancer agents to include PGx information. Given the complexity of this genetic information (e.g., tumor mutation and gene overexpression, chromosomal translocation and germline variations), as well as the variable level of scientific evidence, the FDA recommendation and potential action needed varies among drugs. In this review, we have highlighted some of these PGx discoveries for their scientific values and utility in improving therapeutic efficacy and reducing side effects. Furthermore, examples are also provided for the role of PGx in new anticancer drug development by revealing novel druggable targets.

Full Text

PDF (903 KB)

PDF Plus (935 KB)

Users who read this article also read:

Uncertain prognosis for high-quality diagnostics: clinical challenges, economic barriers and needed reforms Mark R Trusheim , MJ Finley Austin , Carsten Rausch , Ernst R Berndt Pharmacogenomics, Feb 2013, Vol. 14, No. 3, Pages 325-334. Summary | Full Text | PDF (875 KB) | PDF Plus(891 KB) | Add to Favorites | Related | Reprints & Permissions

Methotrexate pharmacogenetics in rheumatoid arthritis: a status report Fardina Malik , Prabha Ranganathan Pharmacogenomics, Feb 2013, Vol. 14, No. 3, Pages 305-314. Summary | Full Text | PDF (924 KB) | PDF Plus(970 KB) | Supplementary Material | Add to Favorites | Related | Reprints & Permissions

Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis Seyed Hamidreza Mahmoudpour , Maarten Leusink , Lisa van der Putten , Ingrid Terreehorst , Folkert W Asselbergs , Anthonius de Boer , Anke H Maitland-van der Zee Pharmacogenomics, Feb 2013, Vol. 14, No. 3, Pages 249-260. Summary | Full Text | PDF (1077 KB) | PDF Plus(1120 KB) | Supplementary Material | Add to Favorites | Related | Reprints & Permissions

Institutional Profile: Institute of Pharmacogenetics at the University Hospital Essen Winfried Siffert Pharmacogenomics, Feb 2013, Vol. 14, No. 3, Pages 241-243. Summary | Full Text | PDF (467 KB) | PDF Plus(467 KB) | Add to Favorites | Related | Reprints & Permissions